Document Detail


Second cancers following non-Hodgkin's lymphoma.
MedLine Citation:
PMID:  2004317     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The risk of second malignancies following non-Hodgkin's lymphoma (NHL) was estimated in 29,153 patients diagnosed with NHL between 1973 and 1987 in one of nine areas participating in the National Cancer Institute's Surveillance, Epidemiology, and End Results Program. Compared with the general population, NHL patients were at a significantly increased risk of developing second cancers (observed/expected [O/E] = 1.18; O = 1231). The O/E ratio increased significantly with time to reach 1.77 in 10-year survivors. Significant excesses were noted for acute nonlymphocytic leukemia (O/E = 2.88), cancers of the bladder (O/E = 1.30), kidney (O/E = 1.47), and lung (O/E = 1.57), malignant melanoma (O/E = 2.44), and Hodgkin's disease (O/E = 4.16). Chemotherapy appeared related to subsequent acute nonlymphocytic leukemia (ANLL) and bladder cancer. Radiation therapy was associated with ANLL and possibly cancers of the lung, bladder, and bone. Malignant melanoma was not clearly related to initial NHL treatment.
Authors:
L B Travis; R E Curtis; J D Boice; B F Hankey; J F Fraumeni
Related Documents :
3539897 - An analysis of the radiation related morbidity observed in a randomized trial of neutro...
9815887 - Phase i clinical study of the recombinant oncotoxin tp40 in superficial bladder cancer.
4064487 - Bladder cancer: the value of routine bone scintigraphy.
8976267 - Radical cystectomy using endoscopic stapling devices: preliminary experience with a sim...
20466497 - Mammography findings following electron intraoperative radiotherapy or external radioth...
1560487 - Impact of schistosomiasis on urinary bladder cancer in the southern province of saudi a...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cancer     Volume:  67     ISSN:  0008-543X     ISO Abbreviation:  Cancer     Publication Date:  1991 Apr 
Date Detail:
Created Date:  1991-04-22     Completed Date:  1991-04-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0374236     Medline TA:  Cancer     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2002-9     Citation Subset:  AIM; IM    
Affiliation:
Epidemiology and Biostatistics Program, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, Maryland 20892.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / adverse effects
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Incidence
Lymphoma, Non-Hodgkin / therapy*
Male
Middle Aged
Neoplasm Staging
Neoplasms, Multiple Primary / epidemiology*,  etiology,  pathology
Neoplasms, Radiation-Induced / epidemiology,  pathology
Risk Factors
Chemical
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sun-induced freckles in children and young adults. A correlation of clinical and histopathologic fea...
Next Document:  Mammography and age: are we targeting the wrong women? A community survey of women and physicians.